{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T08:32:49Z","timestamp":1790497969547,"version":"4.1.0"},"reference-count":35,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Fundaci\u00f3n hna","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CPII13\/00017"],"award-info":[{"award-number":["CPII13\/00017"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI18\/00349"],"award-info":[{"award-number":["PI18\/00349"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["BFU2016-78232-P"],"award-info":[{"award-number":["BFU2016-78232-P"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","award":["BES-2017-080739"],"award-info":[{"award-number":["BES-2017-080739"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010067","name":"Gobierno de Arag\u00f3n","doi-asserted-by":"publisher","award":["E45_20R"],"award-info":[{"award-number":["E45_20R"]}],"id":[{"id":"10.13039\/501100010067","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010067","name":"Gobierno de Arag\u00f3n","doi-asserted-by":"publisher","award":["B25_20R"],"award-info":[{"award-number":["B25_20R"]}],"id":[{"id":"10.13039\/501100010067","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015755","name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/501100015755","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>Inhibiting the main protease 3CLpro is the most common strategy in the search for antiviral drugs to fight the infection from SARS-CoV-2. We report that the natural compound eugenol is able to hamper in vitro the enzymatic activity of 3CLpro, the SARS-CoV-2 main protease, with an inhibition constant in the sub-micromolar range (Ki = 0.81 \u03bcM). Two phenylpropene analogs were also tested: the same effect was observed for estragole with a lower potency (Ki = 4.1 \u03bcM), whereas anethole was less active. The binding efficiency index of these compounds is remarkably favorable due also to their small molecular mass (MW &lt; 165 Da). We envision that nanomolar inhibition of 3CLpro is widely accessible within the chemical space of simple natural compounds.<\/jats:p>","DOI":"10.3390\/ph14090892","type":"journal-article","created":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T23:05:12Z","timestamp":1630623912000},"page":"892","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Sub-Micromolar Inhibition of SARS-CoV-2 3CLpro by Natural Compounds"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1110-764X","authenticated-orcid":false,"given":"Bruno","family":"Rizzuti","sequence":"first","affiliation":[{"name":"CNR-NANOTEC, SS Rende (CS), Department of Physics, University of Calabria, 87036 Rende, Italy"},{"name":"Institute for Biocomputation and Physics of Complex Systems (BIFI), Joint Units IQFR-CSIC-BIFI, and GBsC-CSIC-BIFI, Universidad de Zaragoza, 50018 Zaragoza, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7223-1719","authenticated-orcid":false,"given":"Laura","family":"Ceballos-Laita","sequence":"additional","affiliation":[{"name":"Institute for Biocomputation and Physics of Complex Systems (BIFI), Joint Units IQFR-CSIC-BIFI, and GBsC-CSIC-BIFI, Universidad de Zaragoza, 50018 Zaragoza, Spain"},{"name":"Instituto de Investigaci\u00f3n Sanitaria de Arag\u00f3n (IIS Aragon), 50009 Zaragoza, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1885-4365","authenticated-orcid":false,"given":"David","family":"Ortega-Alarcon","sequence":"additional","affiliation":[{"name":"Institute for Biocomputation and Physics of Complex Systems (BIFI), Joint Units IQFR-CSIC-BIFI, and GBsC-CSIC-BIFI, Universidad de Zaragoza, 50018 Zaragoza, Spain"},{"name":"Departamento de Bioqu\u00edmica y Biolog\u00eda Molecular y Celular, Universidad de Zaragoza, 50009 Zaragoza, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Jimenez-Alesanco","sequence":"additional","affiliation":[{"name":"Institute for Biocomputation and Physics of Complex Systems (BIFI), Joint Units IQFR-CSIC-BIFI, and GBsC-CSIC-BIFI, Universidad de Zaragoza, 50018 Zaragoza, Spain"},{"name":"Departamento de Bioqu\u00edmica y Biolog\u00eda Molecular y Celular, Universidad de Zaragoza, 50009 Zaragoza, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Vega","sequence":"additional","affiliation":[{"name":"Institute for Biocomputation and Physics of Complex Systems (BIFI), Joint Units IQFR-CSIC-BIFI, and GBsC-CSIC-BIFI, Universidad de Zaragoza, 50018 Zaragoza, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6154-4330","authenticated-orcid":false,"given":"Fedora","family":"Grande","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Rende, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6699-005X","authenticated-orcid":false,"given":"Filomena","family":"Conforti","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Rende, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5664-1729","authenticated-orcid":false,"given":"Olga","family":"Abian","sequence":"additional","affiliation":[{"name":"Institute for Biocomputation and Physics of Complex Systems (BIFI), Joint Units IQFR-CSIC-BIFI, and GBsC-CSIC-BIFI, Universidad de Zaragoza, 50018 Zaragoza, Spain"},{"name":"Instituto de Investigaci\u00f3n Sanitaria de Arag\u00f3n (IIS Aragon), 50009 Zaragoza, Spain"},{"name":"Departamento de Bioqu\u00edmica y Biolog\u00eda Molecular y Celular, Universidad de Zaragoza, 50009 Zaragoza, Spain"},{"name":"Instituto Aragon\u00e9s de Ciencias de la Salud (IACS), 50009 Zaragoza, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red en el \u00c1rea Tem\u00e1tica de Enfermedades Hep\u00e1ticas Digestivas (CIBERehd), 28029 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5702-4538","authenticated-orcid":false,"given":"Adrian","family":"Velazquez-Campoy","sequence":"additional","affiliation":[{"name":"Institute for Biocomputation and Physics of Complex Systems (BIFI), Joint Units IQFR-CSIC-BIFI, and GBsC-CSIC-BIFI, Universidad de Zaragoza, 50018 Zaragoza, Spain"},{"name":"Instituto de Investigaci\u00f3n Sanitaria de Arag\u00f3n (IIS Aragon), 50009 Zaragoza, Spain"},{"name":"Departamento de Bioqu\u00edmica y Biolog\u00eda Molecular y Celular, Universidad de Zaragoza, 50009 Zaragoza, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red en el \u00c1rea Tem\u00e1tica de Enfermedades Hep\u00e1ticas Digestivas (CIBERehd), 28029 Madrid, Spain"},{"name":"Fundaci\u00f3n ARAID, Gobierno de Arag\u00f3n, 50018 Zaragoza, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,9,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1056\/NEJMp2032369","article-title":"FDA approval of remdesivir\u2014A step in the right direction","volume":"383","author":"Rubin","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1126\/science.abb4489","article-title":"Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease","volume":"368","author":"Dai","year":"2020","journal-title":"Science"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/s41557-020-0496-2","article-title":"Crowdsourcing drug discovery for pandemics","volume":"12","author":"Chodera","year":"2020","journal-title":"Nat. Chem."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"137489","DOI":"10.1016\/j.cplett.2020.137489","article-title":"Identification of potential binders of the main protease 3CL pro of the COVID-19 via structure-based ligand design and molecular modeling","volume":"750","author":"Macchiagodena","year":"2020","journal-title":"Chem. Phys. Lett."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1021\/acscentsci.1c00039","article-title":"Potent noncovalent inhibitors of the main protease of SARS-CoV-2 from molecular sculpting of the drug perampanel guided by free energy perturbation calculations","volume":"7","author":"Zhang","year":"2021","journal-title":"ACS Cent. Sci."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jpha.2020.03.009","article-title":"Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants","volume":"10","author":"Alqahtani","year":"2020","journal-title":"J. Pharm. Anal."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1080\/14756366.2020.1801672","article-title":"Flavonoids with inhibitory activity against SARS-CoV-2 3CLpro","volume":"35","author":"Jo","year":"2020","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/s41401-020-0483-6","article-title":"Anti-SARS-CoV-2 activities in vitro of Shuanghuanglian preparations and bioactive ingredients","volume":"41","author":"Su","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/j.ijbiomac.2020.07.235","article-title":"Structural stability of SARS-CoV-2 3CLpro and identification of quercetin as an inhibitor by experimental screening","volume":"164","author":"Abian","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Rizzuti, B., Grande, F., Conforti, F., Jimenez-Alesanco, A., Ceballos-Laita, L., Ortega-Alarcon, D., Vega, S., Reyburn, H.T., Abian, O., and Velazquez-Campoy, A. (2021). Rutin is a low micromolar inhibitor of SARS-CoV-2 main protease 3CLpro: Implications for drug design of quercetin analogs. Biomedicines, 9.","DOI":"10.3390\/biomedicines9040375"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijbiomac.2021.02.012","article-title":"Epigallocatechin-3-gallate, an active ingredient of traditional chinese medicines, inhibits the 3CLpro activity of SARS-CoV-2","volume":"176","author":"Du","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"669642","DOI":"10.3389\/fphar.2021.669642","article-title":"Myricetin inhibits SARS-CoV-2 Viral replication by targeting Mpro and ameliorates pulmonary inflammation","volume":"12","author":"Xiao","year":"2021","journal-title":"Front. Pharmacol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1021\/acsptsci.0c00215","article-title":"A blueprint for high affinity SARS-CoV-2 Mpro inhibitors from activity-based compound library screening guided by analysis of protein dynamics","volume":"4","author":"Gossen","year":"2021","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1172\/JCI34355","article-title":"Identification of pharmacological chaperones as potential therapeutic agents to treat phenylketonuria","volume":"118","author":"Pey","year":"2008","journal-title":"J. Clin. Investig."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1021\/cb900166q","article-title":"Discovery of specific flavodoxin inhibitors as potential therapeutic agents against Helicobacter pylori infection","volume":"4","author":"Cremades","year":"2009","journal-title":"ACS Chem. Biol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"39732","DOI":"10.1038\/srep39732","article-title":"Identification of a drug targeting an intrinsically disordered protein involved in pancreatic adenocarcinoma","volume":"7","author":"Neira","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1172\/JCI127223","article-title":"Ligand-based design identifies a potent NUPR1 inhibitor exerting anticancer activity via necroptosis","volume":"129","author":"Xia","year":"2019","journal-title":"J. Clin. Investig."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Mangiavacchi, F., Kula-Pacurar, A., Menichetti, E., Bagnoli, L., Rosati, O., Marini, F., Fonseca, S.F., Abenante, L., Alves, D., and Dabrowska, A. (2021). Seleno-functionalization of quercetin improves the non-covalent inhibition of Mpro and its antiviral activity in cells against SARS-CoV-2. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22137048"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1021\/acs.jafc.6b04696","article-title":"Phenylpropenes: Occurrence, distribution, and biosynthesis in fruit","volume":"66","author":"Atkinson","year":"2018","journal-title":"J. Agric. Food Chem."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"126727","DOI":"10.1016\/j.foodchem.2020.126727","article-title":"A new strategy based on gas chromatography-high resolution mass spectrometry (GC-HRMS-Q-Orbitrap) for the determination of alkenylbenzenes in pepper and its varieties","volume":"321","year":"2020","journal-title":"Food Chem."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.3109\/13880209.2015.1100639","article-title":"The application of anethole, menthone, and eugenol in transdermal penetration of valsartan: Enhancement and mechanistic investigation","volume":"54","author":"Ahad","year":"2016","journal-title":"Pharm. Biol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.abb3405","article-title":"Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved \u03b1-ketoamide inhibitors","volume":"368","author":"Zhang","year":"2020","journal-title":"Science"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s13238-010-0044-8","article-title":"Three-dimensional domain swapping as a mechanism to lock the active conformation in a super-active octamer of SARS-CoV main protease","volume":"1","author":"Zhang","year":"2010","journal-title":"Protein Cell"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"9283","DOI":"10.1038\/s41598-021-88630-9","article-title":"The dimer-monomer equilibrium of SARS-CoV-2 main protease is affected by small molecule inhibitors","volume":"11","author":"Silvestrini","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"17365","DOI":"10.1074\/jbc.AC120.016154","article-title":"Unusual zwitterionic catalytic site of SARS-CoV-2 main protease revealed by neutron crystallography","volume":"295","author":"Kneller","year":"2020","journal-title":"J. Biol. Chem."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"20584","DOI":"10.1038\/s41598-020-77602-0","article-title":"In silico studies evidenced the role of structurally diverse plant secondary metabolites in reducing SARS-CoV-2 pathogenesis","volume":"10","author":"Puttaswamy","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"556481","DOI":"10.3389\/fmolb.2020.556481","article-title":"Discovery of potential flavonoid inhibitors against COVID-19 3CL proteinase based on virtual screening strategy","volume":"7","author":"Xu","year":"2020","journal-title":"Front. Mol. Biosci."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"5047","DOI":"10.1038\/s41467-020-18709-w","article-title":"Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main protease","volume":"11","author":"Douangamath","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Sellamuthu, R. (2014). Eugenol. Encyclopedia of Toxicology, Elsevier.","DOI":"10.1016\/B978-0-12-386454-3.01125-8"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"201","DOI":"10.4274\/tjps.62207","article-title":"Pharmacological and toxicological properties of eugenol","volume":"14","year":"2017","journal-title":"Turk. J. Pharm. Sci."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/1099-1573(200011)14:7<495::AID-PTR650>3.0.CO;2-8","article-title":"In vitro and in vivo activity of eugenol on human herpesvirus","volume":"14","author":"Benencia","year":"2000","journal-title":"Phytother. Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1038\/s41467-021-23751-3","article-title":"Identification of pyrogallol as a warhead in design of covalent inhibitors for the SARS-CoV-2 3CL protease","volume":"12","author":"Su","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Grande, F., Rizzuti, B., Occhiuzzi, M.A., Ioele, G., Casacchia, T., Gelmini, F., Guzzi, R., Garofalo, A., and Statti, G. (2018). Identification by molecular docking of homoisoflavones from Leopoldia comosa as ligands of estrogen receptors. Molecules, 23.","DOI":"10.3390\/molecules23040894"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ejps.2017.11.013","article-title":"Stereoselective and domain-specific effects of ibuprofen on the thermal stability of human serum albumin","volume":"112","author":"Guglielmelli","year":"2018","journal-title":"Eur. J. Pharm. Sci."}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/14\/9\/892\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:54:24Z","timestamp":1760165664000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/14\/9\/892"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,1]]},"references-count":35,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2021,9]]}},"alternative-id":["ph14090892"],"URL":"https:\/\/doi.org\/10.3390\/ph14090892","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,1]]}}}